84.34
+1.66(+2.01%)
Currency In EUR
Sector
Healthcare
Industry
Medical - Equipment & Services
Employees
16741
First IPO Date
January 24, 2007
| Name | Title | Pay | Year Born |
| Mr. Thomas Barfod | Senior Controller & Employees Representative Director | 60,325 | 1970 |
| Mr. Nicolai Buhl Andersen | Executive Vice President of Chronic Care | 938,396 | 1969 |
| Mr. Allan Rasmussen | Executive Vice President of Global Operations | 965,207 | 1967 |
| Mr. Anders Lonning-Skovgaard | Executive Vice President & Chief Financial Officer | 1.11M | 1972 |
| Dorthe Ronnau | Executive Vice President of People & Culture | 0 | 1966 |
| Aleksandra Dimovska | Vice President of Investor Relations | 0 | N/A |
| Mr. Rasmus Hannemann Møller | Senior Vice President of Wound & Skin Care | 0 | N/A |
| Ms. Caroline Vagner Rosenstand | Executive Vice President of Voice & Respiratory Care | 0 | 1979 |
| Mr. Dennis Kaysen | Vice President of Corporate Communications | 0 | N/A |
| Mr. Alain Morvan | Senior Vice President of Sales Europe | 0 | N/A |
Coloplast A/S develops, manufactures, and markets medical products. The company is engaged in the development, marketing and sale of intimate healthcare products and services, targeting people with diseases of private and personal nature. Its operations are structured into four business areas: Ostomy Care offering products for people whose intestinal outlet has been rerouted through the abdominal wall, Continence Care products for people suffering from diseases of and damage to the urinary system, Urology Care products for people suffering from diseases of and damage to the kidneys, the urinary system or the male reproductive system and Wound & Skin Care for the treatment of chronic wounds and skin care products for prevention and treatment. The firm supplies products to hospitals, institutions as well as wholesalers and pharmacies.